Docoh
Loading...

Matthew T. Wiley

Matthew T. Wiley is Chief Commercial Officer of VYNE Therapeutics Inc.

Person profile

Roles
VYNE Therapeutics Chief Commercial Officer
Address
Rehovot, Israel
Employees
SEC CIK

Calendar

16 Jan 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
30 Jun 21 VYNE VYNE Therapeutics Common Stock Payment of exercise Dispose F No No 3.51 5,151 18.08K 109,246
31 Mar 21 VYNE VYNE Therapeutics Common Stock Payment of exercise Dispose F No No 6.84 2,573 17.6K 114,397
22 Feb 21 VYNE VYNE Therapeutics Common Stock Grant Acquire A No No 0 27,675 0 116,970
22 Feb 21 VYNE VYNE Therapeutics Stock Options Common Stock Grant Acquire A No No 8.33 64,575 537.91K 64,575
31 Dec 20 VYNE VYNE Therapeutics Common Stock Payment of exercise Dispose F No No 1.58 1,541 2.43K 357,181
30 Nov 20 VYNE VYNE Therapeutics Common Stock Grant Acquire A No No 1.445 7,838 11.33K 358,722

Financial reports

No filings

Current reports

No filings

Registration and prospectus

No filings

Proxies

No filings

Other

No filings